Spitting In A Tube And Selling It To Private Equity

The chickens have come home to roost for 23andme, the consumer genetic testing company which has gone from making people feel nice about being 4% Italian to languishing in bankruptcy. With the vultures circling the carcass, we reflect on its very weird business model and why it should never have gone public.

Then we talk about Google, which has been cooking on the AI front recently, and how it looks like their overall strategy in that space is coming into focus. 

See omnystudio.com/listener for privacy information.